[1] YANG J, YUAN L, WEN Y, et al. Protective effects of naringin in cerebral infarction and its molecular mechanism[J]. Med Sci Monit, 2020, 26:e918772. [2] DU X, LIU Q, LI Q, et al. Prognostic value of cerebral infarction coefficient in patients with massive cerebral infarction[J]. Clin Neurol Neurosurg, 2020, 196:106009. [3] MO Z, TANG C, LI H, et al. Eicosapentaenoic acid prevents inflammation induced by acute cerebral infarction through inhibition of NLRP3 inflammasome activation[J]. Life Sci, 2020, 242: 117133. [4] 徐小雨, 姚蓓蓓, 朱清, 等. 炎性标志物与缺血性卒中的研究进展[J]. 实用老年医学, 2020, 34(2): 181-185. [5] WEBB G J, HIRSCHFIELD G M, LANE P J. OX40, OX40L and autoimmunity: a comprehensive review[J]. Clin Rev Allergy Immunol, 2016, 50(3): 312-332. [6] KASHIMA J, OKUMA Y, HOSOMI Y, et al. High serum OX40 and OX40 ligand (OX40L) levels correlate with reduced survival in patients with advanced lung adenocarcinoma[J]. Oncology, 2020, 98(5): 303-310. [7] LEI W, ZENG D, LIU G, et al. Crucial role of OX40/OX40L signaling in a murine model of asthma[J]. Mol Med Rep, 2018, 17(3): 4213-4220. [8] WU L Y, ENKHJARGAL B, XIE Z Y, et al. Recombinant OX40 attenuates neuronal apoptosis through OX40-OX40L/PI3K/AKT signaling pathway following subarachnoid hemorrhage in rats[J]. Exp Neurol, 2020, 326: 113179. [9] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9): 666-682. [10] 田慧军, 刘卫卫, 刘晓阳. PLR NLR水平与急性脑梗死患者神经功能缺损严重程度的关系[J]. 山西医药杂志, 2020, 49(9): 1070-1073. [11] 瞿伦学, 李光勤, 费容, 等. 血清正五聚蛋白3和陷窝蛋白1用于评估急性脑梗死溶栓治疗预后的临床价值[J]. 中国动脉硬化杂志, 2019, 27(9): 774-778. [12] XIA C, LI X Q, ZHOU Z H, et al. Identification of cytokines for early prediction of malignant middle cerebral artery infarction[J]. Int J Neurosci, 2017, 127(1): 86-91. [13] KUMAR B V, CONNORS T J, FARBER D L. Human T cell development, localization, and function throughout Life[J]. Immunity, 2018, 48(2): 202-213. [14] 周杨, 刘诚林, 刘俊逸, 等. OX40/OX40L分子在人活化T细胞上的表达特性及其生物学功能研究[J]. 中国血液流变学杂志, 2016, 26(2): 143-147. [15] WANG X, LUAN Y, ZHANG C. A meta-analysis on correlations of OX40L variants with atherosclerotic disorders[J]. J Cell Biochem, 2019, 120(6): 9624-9630. [16] HE Y, ZHANG X, JIA K, et al. OX40 and OX40L protein expression of tumor infiltrating lymphocytes in non-small cell lung cancer and its role in clinical outcome and relationships with other immune biomarkers[J]. Transl Lung Cancer Res, 2019, 8(4): 352-366. |